Application YC di Evolvere BioSciences

Summer 2024Active

Evolvere BioSciences ha partecipato a Y Combinator nel batch Summer 2024 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2024
Settore: HealthcareTherapeutics
Dimensione team: 3
Stato: Active
Lanciata: 2024

Founder

Adam WinnifrithFounder
Piotr JedryszekFounder
Weronika SlesakFounder

Cosa fa Evolvere BioSciences

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. 🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️. We are a team of biochemists and evolutionary biologists who met at the University of Oxford.

Application YC di Evolvere BioSciences, ricostruita

Domanda per Y Combinator

Evolvere BioSciences, batch Summer 2024. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Evolvere BioSciences

Describe what your company does in 50 characters or less.

Next-gen antibiotics outpace bacterial resistance

What is your company going to make? Please describe your product and what it does or will do.

We build computational models that predict how bacteria will evolve resistance to antibiotics. Using those forecasts, we design antibiotics that bacteria can't easily outsmart, targeting only harmful bacteria and sparing beneficial microbes and human cells.

Where do you live now, and where would the company be based after YC?

We live in Oxford, England, and would base the company there after YC.

Explain your decision regarding location.

We're rooted in Oxford because we met here at the University of Oxford as biochemists and evolutionary biologists. The region's scientific environment and access to expertise are vital for our work.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Evolvere BioSciences?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Evolvere BioSciences (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Evolvere BioSciences si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Evolvere BioSciences?

Evolvere BioSciences apparteneva al batch Summer 2024 di Y Combinator.

Chi ha fondato Evolvere BioSciences?

Evolvere BioSciences è stato fondato da Adam Winnifrith, Piotr Jedryszek, Weronika Slesak.

Cosa fa Evolvere BioSciences?

Making Next-Generation Antibiotics that Outpace Bacterial Evolution

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Evolvere BioSciences, e di ogni altro batch YC, è in YC Insights.